185 related articles for article (PubMed ID: 19999392)
1. Concurrence of multiple myeloma and idiopathic erythrocytosis.
Chang H; Shih LY
Acta Clin Belg; 2009; 64(5):434-5. PubMed ID: 19999392
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
3. Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels.
Shih LY; Lee CT; Ou YC
Exp Hematol; 1997 Apr; 25(4):288-92. PubMed ID: 9131002
[TBL] [Abstract][Full Text] [Related]
4. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
5. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.
Randi ML; Bertozzi I; Cosi E; Santarossa C; Peroni E; Fabris F
Ann Hematol; 2016 Jan; 95(2):233-7. PubMed ID: 26547864
[TBL] [Abstract][Full Text] [Related]
7. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Thurmes PJ; Steensma DP
Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
[TBL] [Abstract][Full Text] [Related]
9. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
10. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
11. The complete evaluation of erythrocytosis: congenital and acquired.
Patnaik MM; Tefferi A
Leukemia; 2009 May; 23(5):834-44. PubMed ID: 19295544
[TBL] [Abstract][Full Text] [Related]
12. "Benign erythrocytosis" and other familial and congenital polycythemias.
Prchal JT; Sokol L
Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
[TBL] [Abstract][Full Text] [Related]
13. [Myeloproliferative masks of multiple myeloma: A review of literature and clinical case reports].
Ryzhko VV; Grachev AE; Klodzinsky AA; Ivanova TV; Sataeva MS; Gribanova EO
Ter Arkh; 2017; 89(1):72-77. PubMed ID: 28252631
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic erythrocytosis in dialysis patients: a case report and literature review.
Sheqwara J; Alkhatib Y; Dabak V; Kuriakose P
Am J Nephrol; 2013; 37(4):333-8. PubMed ID: 23548871
[TBL] [Abstract][Full Text] [Related]
15. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
16. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
[TBL] [Abstract][Full Text] [Related]
17. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing polycythemia vera: a paradigm shift.
Tefferi A
Mayo Clin Proc; 1999 Feb; 74(2):159-62. PubMed ID: 10069355
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Polycythemia Vera with Newly Diagnosed Multiple Myeloma: Case Report and Literature Review.
Yuan J; Liu X; Wang Z; Li L; Wang F
J Inflamm Res; 2023; 16():4117-4121. PubMed ID: 37745792
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients.
Mori Y; Araki M; Morishita S; Imai M; Edahiro Y; Ito M; Ochiai T; Shirane S; Hashimoto Y; Yasuda H; Ando J; Ando M; Komatsu N
Cancer Med; 2023 Jan; 12(2):1079-1089. PubMed ID: 35775283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
